Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator instructions] I would now like to turn the conference over to your host, Mike Czapar, ...

These drugs do not cause diabetic ketoacidosis, like occasionally SGLT2 inhibitors can, because these medications increase insulin levels while reducing body fat. The initial incretin mimetics ...

An impaired incretin system, characterized by decreased responsiveness ... exhibits the glucoregulatory actions of GLP-1 and reduces body weight in patients with T2DM. It may possess ...

GLP-1, the second incretin to be identified ... Since sugar, in the form of glucose, provides energy for every cell and system in the body, when there’s too much of it, all sorts of things ...

GLP-1, the second incretin to be identified ... Since sugar, in the form of glucose, provides energy for every cell and system in the body, when there’s too much of it, all sorts of things get out of ...

The hormone insulin plays a central role in the metabolism of many living organisms. When food is plentiful, insulin promotes ...

How does the body regulate the activity of insulin-producing cells in order to react quickly to changing conditions? Researchers have investigated this question.

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

In times of hunger, however, insulin secretion is reduced; the body conserves energy or searches for alternative energy sources. It is crucial for survival that this system is finely tuned.

Participants were given scans to evaluate their heart function, while CT scans were used to analyse body composition and ... potentially damaging vascular systems and the heart muscle.

The second meal effect refers to the phenomenon in which the Glycemic Index GI of a preceding meal can have a lasting impact ...